We found that patients with high expression of three m6A regulators in TCGA dataset (Figure 2E) and nine m6A regulators in the GEO dataset (Figure S6A) had a significantly worse outcome than those with low expression, suggesting that high expression of m6A regulators might have accelerated the progression of the tumor. Here, METTL3 is linked to neoplasm.